Top compounds associated with response to EEF1A2


Feature Type Standardized
Nominal ANOVA
mRNA Bortezomib GDSC1000 pan-cancer AAC -0.14 0.02
mRNA ML311 CTRPv2 pan-cancer AAC -0.079 0.02
mRNA clofarabine CTRPv2 pan-cancer AAC -0.071 0.02
mRNA A-443654 GDSC1000 pan-cancer AAC -0.14 0.02
mRNA AICAR GDSC1000 pan-cancer AAC 0.077 0.03
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.081 0.03
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.086 0.03
mRNA VX-680 GDSC1000 pan-cancer AAC -0.14 0.03
mRNA ABT-263 CTRPv2 pan-cancer AAC -0.085 0.03
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.086 0.03
Download CSV